Lynette Purdue

2.0k citations

17 papers · 746 indexed · h-index 15

Impact in

Virology top 1%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in ⓘ

Virology 10
- HIV Research and Treatment 10
Infectious Diseases 12
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 6
- Leprosy Research and Treatment 1

Co-authors: Paul Palumbo (5 shared papers)Lynne Mofenson (5 shared papers)Michael D. Hughes (5 shared papers)Patrick Jean‐Philippe (4 shared papers)Portia Kamthunzi (2 shared papers)Jane C. Lindsey (2 shared papers)Elaine J. Abrams (2 shared papers)Elizabeth Petzold (2 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)New England Journal of Medicine (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)The Journal of Infectious Diseases (2 papers)The Pediatric Infectious Disease Journal (2 papers)
Partner nations: United States South Africa Zambia

In The Last Decade

Lynette Purdue

17 papers receiving 725 citations

Peers

Countries citing papers authored by Lynette Purdue

Since Specialization

Citations

This map shows the geographic impact of Lynette Purdue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette Purdue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette Purdue more than expected).

Fields of papers citing papers by Lynette Purdue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette Purdue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette Purdue. The network helps show where Lynette Purdue may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynette Purdue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynette Purdue Line = papers co-authored together Lynette Purdue links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure New England Journal of Medicine ·Paul Palumbo, Jane C. Lindsey, Michael D. Hughes, Mark F. Cotton, Raziya Bobat, Tammy Meyers, Mutsa Bwakura‐Dangarembizi, H. Benjamin, Philippa Musoke, Portia Kamthunzi, Werner Schimana, Lynette Purdue, Susan H. Eshleman, Elaine J. Abrams, Linda Millar, Elizabeth Petzold, Lynne Mofenson, Patrick Jean‐Philippe, Avy Violari	2010	172
2	Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children New England Journal of Medicine ·Avy Violari, Jane C. Lindsey, Michael D. Hughes, Hilda Mujuru, Linda Barlow‐Mosha, Portia Kamthunzi, H. Benjamin, Mark F. Cotton, Harry Moultrie, Sandhya Khadse, Werner Schimana, Raziya Bobat, Lynette Purdue, Susan H. Eshleman, Elaine J. Abrams, Linda Millar, Elizabeth Petzold, Lynne Mofenson, Patrick Jean‐Philippe, Paul Palumbo	2012	150
3	A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy Vaccine ·Rajesh T. Gandhi, David O’Neill, Ronald J. Bosch, Ellen S. Chan, R. Pat Bucy, Janet Shopis, Lynn Baglyos, Elizabeth M. Adams, Lawrence Fox, Lynette Purdue, Ann Marshak, Theresa Flynn, Reena Masih, Barbara Schock, Donna Mildvan, Sarah J. Schlesinger, Mary Marovich, Nina Bhardwaj, Jeffrey M. Jacobson	2009	67
4	Evidence That Intermittent Structured Treatment Interruption, but Not Immunization with ALVAC‐HIV vCP1452, Promotes Host Control of HIV Replication: The Results of AIDS Clinical Trials Group 5068 The Journal of Infectious Diseases ·Jeffrey M. Jacobson, R. Pat Bucy, John Spritzler, Michael S. Saag, Joseph J. Eron, Robert W. Coombs, Rui Wang, Lawrence Fox, Victoria A. Johnson, Susan Cu‐Uvin, Susan E. Cohn, Donna Mildvan, Dorothy O’Neill, Jennifer Janik, Lynette Purdue, Deborah K. O’Connor, Christine Di Vita, Ian Frank	2006	66
5	Early Initiation of Lopinavir/Ritonavir in Infants Less Than 6 Weeks of Age The Pediatric Infectious Disease Journal ·Ellen G. Chadwick, Jorge Pinto, Ram Yogev, Carmelita Alvero, Michael D. Hughes, Paul Palumbo, Brian L. Robbins, Rohan Hazra, Leslie Serchuck, Barbara Heckman, Lynette Purdue, Renee Browning, Katherine Luzuriaga, Jack Rodman, Edmund V. Capparelli	2009	44
6	A Study of the Immunology, Virology, and Safety of Prednisone in HIV-1–Infected Subjects with CD4 Cell Counts of 200 to 700 mm−3 JAIDS Journal of Acquired Immune Deficiency Syndromes ·Robert S. Wallis, Robert C. Kalayjian, Jeffrey M. Jacobson, Lawrence Fox, Lynette Purdue, Cecilia M. Shikuma, Richard F. Arakaki, S W Snyder, Robert W. Coombs, Ronald J. Bosch, John Spritzler, Miriam Chernoff, Evgenia Aga, Laurie Myers, Barbara Schock, Michael M. Lederman	2003	39
7	Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353 HIV Clinical Trials ·Yvonne J. Bryson, Mark Mirochnick, Alice Stek, Lynne Mofenson, James D. Connor, Edmund V. Capparelli, D. Heather Watts, Sharon Huang, Michael D. Hughes, Kathleen A. Kaiser, Lynette Purdue, Yohannes G. Asfaw, Michael A. Keller, Elizabeth Smith, (unknown)	2008	35
8	Safety and antiretroviral activity of chronic subcutaneous administration of T-20 in human immunodeficiency virus 1-infected children The Pediatric Infectious Disease Journal ·Joseph A. Church, Coleen K. Cunningham, Michael Hughes, Paul Palumbo, Lynne Mofenson, Patricia DeLora, Elizabeth Smith, Andrew Wiznia, Lynette Purdue, Elizabeth Hawkins, Prakash Sista	2002	32
9	The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 AIDS Research and Human Retroviruses ·Jeffrey M. Jacobson, Steven E. Bosinger, Minhee Kang, Pablo F. Belaunzarán-Zamudio, Roy M. Matining, Cara C. Wilson, Charles Flexner, Brian Clagett, Jill Plants, Sarah Read, Lynette Purdue, Laurie Myers, Linda Boone, Pablo Tebas, Princy Kumar, David B. Clifford, Daniel C. Douek, Guido Silvestri, Alan Landay, Michael M. Lederman	2016	28
10	Use of Human Immunodeficiency Virus (HIV) Human Hyperimmune Immunoglobulin in HIV Type 1–Infected Children (Pediatric AIDS Clinical Trials Group Protocol 273) The Journal of Infectious Diseases ·E. Richard Stiehm, Courtney V. Fletcher, Lynne Mofenson, Paul Palumbo, Minhee Kang, Terry Fenton, Christine V. Sapan, William A. Meyer, William T. Shearer, Elizabeth Hawkins, Mary Glenn Fowler, Pamela Bouquin, Lynette Purdue, Elaine M. Sloand, George J. Nemo, Diane W. Wara, Yvonne J. Bryson, Stuart E. Starr, Ann Petru, Sandra Burchett	2000	21
11	Safety and Immunogenicity of Zoster Vaccine Live in Human Immunodeficiency Virus–Infected Adults With CD4+ Cell Counts >200 Cells/mL Virologically Suppressed on Antiretroviral Therapy Clinical Infectious Diseases ·Constance A. Benson, Janet W. Andersen, Bernard Macatangay, Robbie B. Mailliard, Charles R. Rinaldo, Sarah Read, Dawn R. Bozzolo, Lynette Purdue, Cheryl Jennings, Michael C. Keefer, Marshall J. Glesby, Pablo Tebas, Amy Falk Russell, Jason Martin, Paula W. Annunziato, Zoran Popmihajlov, Jeffrey L. Lennox	2018	21
12	Single-Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1 Antimicrobial Agents and Chemotherapy ·Walter T. Hughes, Jerry L. Shenep, John H. Rodman, Arnold Fridland, RODNEY P.N. WILLOUGHBY, Suzette Blanchard, Lynette Purdue, Dion F. Coakley, Kenneth C. Cundy, Mary Culnane, Bonnie Zimmer, Sandra Burchett, Jennifer S. Read	2000	17
13	CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection AIDS ·Carolyn Bolton‐Moore, Edmund V. Capparelli, Pearl Samson, Mutsa Bwakura‐Dangarembizi, Patrick Jean‐Philippe, Carol Worrell, Barbara Heckman, Lynette Purdue, Stephen A. Spector, Alex Benns, William Borkowsky, Amy James Loftis, Elizabeth Hawkins, Carole L. Wallis, Ellen G. Chadwick	2017	17
14	Phase I Safety and Pharmacokinetics Study of Micronized Atovaquone in Human Immunodeficiency Virus-Infected Infants and Children Antimicrobial Agents and Chemotherapy ·Walter Hughes, Alejandro Dorenbaum, Ram Yogev, Belinda Beauchamp, Jing Xu, James McNamara, Jack Moye, Lynette Purdue, Russell Van Dyke, Michael M. Rogers, Brian M. Sadler	1998	17
15	A Randomized Controlled Trial of Palifermin (Recombinant Human Keratinocyte Growth Factor) for the Treatment of Inadequate CD4+ T-Lymphocyte Recovery in Patients with HIV-1 Infection on Antiretroviral Therapy JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jeffrey M. Jacobson, Hongying Wang, Rebeka Bordi, Lu Zheng, Barry H. Gross, Alan Landay, John Spritzler, Jean‐Pierre Routy, Constance A. Benson, Judith A. Aberg, Pablo Tebas, David W. Haas, Jennifer Tiu, Kristine Coughlin, Lynette Purdue, Rafick‐Pierre Sékaly	2014	14
16	Randomized Controlled Trial of Feeding a Concentrated Formula to Infants Born to Women Infected by Human Immunodeficiency Virus Journal of Pediatric Gastroenterology and Nutrition ·Harland S. Winter, James M. Oleske, Michael D. Hughes, Ross E. McKinney, Carol Elgie, Christine Powell, Lynette Purdue, Ana M. Puga, Eleanor Jiménez, Gwendolyn B. Scott, Maria Letícia Santos Cruz, Jack Moye	2009	4
17	Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mutsa Dangarembizi, Pearl Samson, Edmund V. Capparelli, Carolyn Bolton‐Moore, Patrick Jean‐Philippe, Stephen A. Spector, Nahida Chakhtoura, Alex Benns, Bonnie Zimmer, Lynette Purdue, C.D. Jackson, Carole L. Wallis, Jennifer Libous, Ellen G. Chadwick, (unknown)	2019	2

About Lynette Purdue

Lynette Purdue is a scholar working on Virology, Infectious Diseases, Hematology, Epidemiology and Immunology, having authored 17 papers that have together received 746 indexed citations. Recurring topics across this work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Pharmacological Effects and Toxicity Studies (1 paper), Leprosy Research and Treatment (1 paper), Blood groups and transfusion (1 paper) and Acne and Rosacea Treatments and Effects (1 paper). The work is most often cited by research in Virology (444 citations), Infectious Diseases (572 citations), Emergency Medicine (140 citations), Epidemiology (168 citations) and Immunology (96 citations). Lynette Purdue has collaborated with scholars based in United States, South Africa and Zambia. Frequent co-authors include Paul Palumbo, Lynne Mofenson, Michael D. Hughes, Patrick Jean‐Philippe, Portia Kamthunzi, Jane C. Lindsey, Elaine J. Abrams, Elizabeth Petzold, Susan H. Eshleman and Avy Violari. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, The Journal of Infectious Diseases and The Pediatric Infectious Disease Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact